Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice

Mucosal Immunology

Volumn 7, Issue 6, 2014, Pages 1429-1439

  Park, M Y ^a   Srivastava, N ^a   Sudan, R ^a   Viernes, D R ^b   Chisholm, J D ^b   Engelman, R W ^c   Kerr, W G ^a,b,d  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 8 INHIBITOR; FAS LIGAND; PROTEIN SHIP1; REGULATOR PROTEIN; UNCLASSIFIED DRUG; CASP8 PROTEIN, MOUSE; FAS ANTIGEN; FASL PROTEIN, MOUSE; INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; INNATE IMMUNITY; LUNG; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMALL INTESTINE; ANIMAL; CROHN DISEASE; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; PATHOLOGY; PNEUMONIA; RESPIRATORY TRACT MUCOSA; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; CASPASE 8; CELL SURVIVAL; CROHN DISEASE; FAS LIGAND PROTEIN; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; PHOSPHORIC MONOESTER HYDROLASES; PNEUMONIA; RESPIRATORY MUCOSA; T-LYMPHOCYTES;

EID: 84908217629     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.32     Document Type: Article

References (39)

1. Kerr, W. G., Park, M. Y., Maubert, M. & Engelman, R. W. SHIP deficiency causes Crohn's disease-like ileitis. Gut 60, 177-188 (2011).
2. Helgason, C. D. et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12, 1610-1620 (1998).
3. Brooks, R. et al. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J. Immunol. 184, 3582-3589 (2010).
4. Smith, A. M. et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 206, 1883-1897 (2009).
5. Collazo, M. M. et al. SHIP limits immunoregulatory capacity in the T-cell compartment. Blood 113, 2934-2944 (2009).
6. Kashiwada, M. et al. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4CD25 T cell development. J. Immunol. 176, 3958-3965 (2006).
7. Locke,N. R. et al. SHIP regulates the reciprocal development of Tregulatory and Th17 cells. J. Immunol. 183, 975-983 (2009).
8. Charlier, E. et al. SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. Leukemia 24, 821-832 (2010).
9. Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med. 6, 583-588 (2000).
10. Mudter, J. & Neurath, M. F. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56, 293-303 (2007).
11. Marks, D. J., Rahman, F. Z., Sewell, G. W. & Segal, A. W. Crohn's disease: an immune deficiency state. Clin. Rev. Allergy immunol. 38, 20-31 (2010).
12. Olsson, J. et al. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J. Infect. Dis. 182, 1625-1635 (2000).
13. Kamat, A., Ancuta, P., Blumberg, R. S. & Gabuzda, D. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS ONE 5, e15533 (2010).
14. Sankaran, S. et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl Acad. Sci. USA 102, 9860-9865 (2005).
15. Fevrier, M., Dorgham, K. & Rebollo, A. CD4 T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses 3, 586-612 (2011).
16. De Maria, R. et al. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest. 97, 316-322 (1996).
17. Kerr, W. G. Inhibitor and activator: dual functions for SHIP in immunity and cancer. Ann. N. Y. Acad. Sci. 1217, 1-17 (2011).
18. Collazo, M. M., Paraiso, K. H., Park, M. Y., Hazen, A. L. & Kerr,W. G. Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP. Eur. J. Immunol. 42, 1785-1795 (2012).
19. Desponts, C., Hazen, A. L., Paraiso, K. H. & Kerr, W. G. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood 107, 4338-4345 (2006).
20. Yuan, Y. H. et al. Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm. Bowel Dis. 7, 281-286 (2001).
21. Papadakis, K. A. et al. Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa. Inflamm. Bowel Dis. 10, 778-788 (2004).
22. Lynch, D. H., Ramsdell, F. & Alderson, M. R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16, 569-574 (1995).
23. Callard, R. E., Stark, J. & Yates, A. J. Fratricide: amechanism for Tmemorycell homeostasis. Trends Immunol. 24, 370-375 (2003).
24. Sobek, V., Balkow, S., Korner, H. & Simon, M. M. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur. J. Immunol. 32, 2490-2499 (2002).
25. Baatar, D. et al. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4 Tregs and unprimed CCR4-Tregs, regulate effector T cells using FasL. J. Immunol. 178, 4891-4900 (2007).
26. Gorbachev, A. V. & Fairchild, R. L. CD4CD25 regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses. Eur. J. Immunol. 40, 2006-2015 (2010).
27. Strauss, L., Bergmann, C. & Whiteside, T. L. Human circulating CD4 CD25highFoxp3 regulatory Tcells kill autologous CD8 but not CD4 responder cells by Fas-mediated apoptosis. J. Immunol. 182, 1469-1480 (2009).
28. Singh, N. et al. CD4()CD25() regulatory T cells resist a novel form of CD28-and Fas-dependent p53-induced Tcell apoptosis. J. Immunol. 184, 94-104 (2010).
29. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449-1456 (1995).
30. Van Parijs, L. & Abbas, A. K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243-248 (1998).
31. Liu, Q. et al. SHIP is a negative regulator of growth factor receptormediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13, 786-791 (1999).
32. Askenasy, N. Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity. Autoimmun. Rev. 12, 972-975 (2013).
33. Kaminitz, A. et al. Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice. J. Autoimmun. 37, 39-47 (2011).
34. Yolcu, E. S. et al. Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease. Exp. Hematol. 41, 903-911 (2013).
35. Glocker, E. & Grimbacher, B. Inflammatory bowel disease: is it a primary immunodeficiency?. Cell. Mol. Life Sci. 69, 41-48 (2012).
36. Fuhler,G. M. et al. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol. Med. 18, 65-75 (2012).
37. Yu, Q. T., Saruta, M. & Papadakis, K. A. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin. Immunol. 127, 322-329 (2008).
38. Wang, J. W. et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295, 2094-2097 (2002).
39. Karlsson, M. C. et al. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198, 333-340 (2003).